Fig. 2From: Two-year assessment of the efficacy and safety of sitagliptin in elderly patients with type 2 diabetes: Post hoc analysis of the ASSET-K studyChanges in body weight over the 2-year observation period. ANOVA, analysis of varianceBack to article page